Copertina

Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies

Hepatocellular carcinoma (HCC) is one of the most common digestive malignancies. HCC It ranges as the fifth most common cause of cancer mortality worldwide. While The prognosis of metastatic or advanced HCC is still quite poor. Recently, locoregional treatment, especially local ablation therapies, p...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Chunying Xiao (Autore), Sheng Liu (Autore), Ge Ge (Autore), Hao Jiang (Autore), Liezhi Wang (Autore), Qi Chen (Autore), Chong Jin (Autore), Jinggang Mo (Autore), Jin Li (Autore), Kunpeng Wang (Autore), Qianqian Zhang (Autore), Jianyu Zhou (Autore)
Natura:	Libro
Pubblicazione:	Frontiers Media S.A., 2023-02-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The mechanism of flavonoids from Cyclocarya paliurus on inhibiting liver cancer based on in vitro experiments and network pharmacology
di: Jinggang Mo, et al.
Pubblicazione: (2023)

Combination of transcriptomic and proteomic approaches helps unravel the mechanisms of luteolin in inducing liver cancer cell death via targeting AKT1 and SRC
di: Junxia Ma, et al.
Pubblicazione: (2024)

Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
di: Seungchul Han, et al.
Pubblicazione: (2024)

Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
di: Jae Hwan Lee, et al.
Pubblicazione: (2024)

Recent technical advances in radiofrequency ablations for hepatocellular carcinoma
di: Dong Ho Lee
Pubblicazione: (2021)

Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
di: Zizhuo Wang, et al.
Pubblicazione: (2024)

THE PERCUTANEOUS CHEMICAL ABLATION APPLICATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA
di: Lyudmila Levchenko, et al.
Pubblicazione: (2020)

Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites
di: Yawen Zou, et al.
Pubblicazione: (2023)

TACE-Sorafenib With Thermal Ablation Has Survival Benefits in Patients With Huge Unresectable Hepatocellular Carcinoma
di: Ying Wu, et al.
Pubblicazione: (2020)

Practical consensus multi-specialty guidelines on image-guided ablation for hepatocellular carcinoma
di: David S. Lu
Pubblicazione: (2024)

A hypoxia-glycolysis-lactate-related gene signature for prognosis prediction in hepatocellular carcinoma
di: Xiaodan Qin, et al.
Pubblicazione: (2024)

Antiproliferative Effect of Echinacoside on Rat Pulmonary Artery Smooth Muscle Cells Under Hypoxia
di: Xiang-Yun Gai, et al.
Pubblicazione: (2014)

Prognostic Hypoxia-Angiogenesis-Related Gene Signature in Hepatocellular Carcinoma, in Which HILPDA Contributes to Tumor Progression
di: Wang S, et al.
Pubblicazione: (2024)

The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma
di: Man Wang, et al.
Pubblicazione: (2020)

Chemotherapeutic Nanoparticle-Based Liposomes Enhance the Efficiency of Mild Microwave Ablation in Hepatocellular Carcinoma Therapy
di: Songsong Wu, et al.
Pubblicazione: (2020)

Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression
di: Rui Cui, et al.
Pubblicazione: (2022)

Gamma linolic acid regulates PHD2 mediated hypoxia and mitochondrial apoptosis in DEN induced Hepatocellular carcinoma
di: Cui H, et al.
Pubblicazione: (2018)

Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial
di: Tae Hoon Kim, et al.
Pubblicazione: (2021)

Radiofrequency Ablation versus Resection in Large Single Nodule of Hepatocellular Carcinoma: an Evidence-based Case Report
di: Felix Firyanto Widjaja, et al.
Pubblicazione: (2019)

Cure can be achieved by conversion to microwave ablation following atezolizumab-bevacizumab therapy in unresectable hepatocellular carcinoma
di: Rene John D. Febro, et al.
Pubblicazione: (2024)

miR-140-3p enhanced the osteo/odontogenic differentiation of DPSCs via inhibiting KMT5B under hypoxia condition
di: Han Zheng, et al.
Pubblicazione: (2021)

Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study
di: Kazuya Kariyama, et al.
Pubblicazione: (2024)

The Death of Lichtenstein Hernioplasty under Local Anesthesia in China
di: Guo-Sheng Wang
Pubblicazione: (2013)

The Death of Lichtenstein Hernioplasty under Local Anesthesia in China.
di: Guo-Sheng Wang
Pubblicazione: (2013)

The overall survival rate for patients with hepatocellular carcinoma who underwent hepatic resection or radiofrequency ablation procedure for curative intent
di: Aisha K Al-Raddadi, et al.
Pubblicazione: (2019)

Comparison of local ablation with Albendazole or laparoscopic hepatectomy combined with Albendazole in the treatment of early hepatic alveolar echinococcosis
di: Jide A, et al.
Pubblicazione: (2022)

COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma
di: Jue Chen, et al.
Pubblicazione: (2024)

Selection and Characterization of a Novel DNA Aptamer, Apt-07S Specific to Hepatocellular Carcinoma Cells
di: Yu XX, et al.
Pubblicazione: (2020)

Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE
di: Tang Liang, et al.
Pubblicazione: (2009)

Letter regarding "Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study"
di: Jongman Kim
Pubblicazione: (2024)

The role of RNA modification in hepatocellular carcinoma
di: Qiang Feng, et al.
Pubblicazione: (2022)

Melatonin enhances the efficacy of anti-PD-L1 by improving hypoxia in residual tumors after insufficient radiofrequency ablation
di: Yanqiao Ren, et al.
Pubblicazione: (2024)

Rhabdomyolysis-Induced Acute Kidney Injury Under Hypoxia and Deprivation of Food and Water
di: Jingwen Wang, et al.
Pubblicazione: (2013)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
di: Luo M, et al.
Pubblicazione: (2021)

Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review
di: He ZX, et al.
Pubblicazione: (2016)

Reply to the Letter regarding "Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study"
di: Kazuhiro Nouso, et al.
Pubblicazione: (2024)

'Thinking globally acting locally' in cryoballoon-based atrial fibrillation ablation
di: Burak Hünük
Pubblicazione: (2017)

Integrative molecular analysis of metastatic hepatocellular carcinoma
di: Dongfang Wang, et al.
Pubblicazione: (2019)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
di: Luo M, et al.
Pubblicazione: (2021)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
di: Zhenyu Zhang, et al.
Pubblicazione: (2022)